IBOC Stock Analysis: International Bancshares | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 4.211m USD | 12M Return: 2.8% | US4590441030 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 16.3M
EPS Trend: 67.0%
Qual. Beats: 0
Rev. Trend: 72.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
International Bancshares Corporation (NASDAQ: IBOC) is a Laredo, Texas-based multibank financial holding company founded in 1966 that provides commercial and retail banking services across Texas and Oklahoma. Its core activities include accepting checking and savings deposits and originating a range of loans, such as commercial, real estate, personal, home improvement, automobile, and installment/term loans, supplemented by international banking offerings like letters of credit, commercial and industrial lending, and foreign exchange.
In addition to traditional banking services such as credit cards, safety deposit boxes, escrow, collections, and drive-up/walk-up facilities, the company provides internet and mobile banking and distributes securities products through third-party providers, distributing these services through an ATM network and retail locations that include shopping malls. As a GICS-classified Regional Bank, IBOC operates under the multibank holding company structure common among U.S. regional lenders, which allows a single parent to own multiple separately chartered bank subsidiaries serving defined geographic markets; the company completed its IPO on May 30, 1996, and currently sits in the mid-cap segment with a market capitalization of $4,322M USD.
- Texas loan demand growth drives net interest income
- Laredo border market fuels deposit and international banking growth
- Federal Reserve rate cuts pressure net interest margin
| Net Income: 419.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.95 > 1.0 |
| NWC/Revenue: 2.29% < 20% (prev -725.1%; Δ 727.4% < -1%) |
| CFO/TA 0.01 > 3% & CFO 139.9m > Net Income 419.4m |
| Net Debt (-54.3m) to EBITDA (729.0m): -0.07 < 3 |
| Current Ratio: 1.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (62.2m) vs 12m ago -0.03% < -2% |
| Gross Margin: 77.58% > 18% (prev 78.35%; Δ -0.77% > 0.5%) |
| Asset Turnover: 6.03% > 50% (prev 6.34%; Δ -0.30% > 0%) |
| Interest Coverage Ratio: 3.48 > 6 (EBIT TTM 703.9m / Interest Expense TTM 202.1m) |
| A: 0.00 (Total Current Assets 608.9m - Total Current Liabilities 585.5m) / Total Assets 17.3b |
| B: 0.23 (Retained Earnings 3.90b / Total Assets 17.3b) |
| C: 0.04 (EBIT TTM 703.9m / Avg Total Assets 16.9b) |
| D: 0.24 (Book Value of Equity 3.34b / Total Liabilities 13.9b) |
| Altman-Z'' = 1.28 = BB |
| DSRI: 1.10 (Receivables 83.0m/77.5m, Revenue 1.02b/1.05b) |
| GMI: 1.01 (GM 78.35% / 77.58%) |
| AQI: 1.47 (AQ_t 0.94 / AQ_t-1 0.64) |
| SGI: 0.97 (Revenue 1.02b / 1.05b) |
| TATA: 0.02 (NI 419.4m - CFO 139.9m) / TA 17.3b) |
| Beneish M = -2.67 (Cap -4..+1) = A |
As of November 20, 2026, the stock is trading at USD 64.71 with a total of 298,363 shares traded. Over the past week, the price has changed by -4.15%, over one month by -2.01%, over three months by -9.53% and over the past year by +2.76%.
Current recommended Stop Loss: 62.70 (which is 3.1% or 1.3 ATR below the current price).
International Bancshares has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy IBOC.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 82 | 26.7% |
P/E Trailing = 10.0684
P/E Forward = 9.8135
P/S = 4.9625
P/B = 1.2564
P/EG = 0.9812
Revenue TTM = 1.02b USD
EBIT TTM = 703.9m USD
EBITDA TTM = 729.0m USD
Long Term Debt = 119.0m USD (from longTermDebt, last quarter)
Short Term Debt = 30.0m USD (from shortLongTermDebt, last quarter)
Debt = 704.7m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -54.3m USD (calculated: Debt 704.7m - CCE 759.0m)
Enterprise Value = 4.16b USD (4.21b + Debt 704.7m - CCE 759.0m)
Interest Coverage Ratio = 3.48 (Ebit TTM 703.9m / Interest Expense TTM 202.1m)
EV/FCF = 30.57x (Enterprise Value 4.16b / FCF TTM 136.0m)
FCF Yield = 3.27% (FCF TTM 136.0m / Enterprise Value 4.16b)
FCF Margin = 13.32% (FCF TTM 136.0m / Revenue TTM 1.02b)
Net Margin = 41.07% (Net Income TTM 419.4m / Revenue TTM 1.02b)
Gross Margin = 77.58% ((Revenue TTM 1.02b - Cost of Revenue TTM 228.9m) / Revenue TTM)
Gross Margin QoQ = none% (prev 77.13%)
Tobins Q-Ratio = 0.24 (Enterprise Value 4.16b / Total Assets 17.3b)
Interest Expense / Debt = 28.68% (Interest Expense 202.1m / Debt 704.7m)
Taxrate = 22.43% (112.6m / 501.8m)
NOPAT = 546.0m (EBIT 703.9m * (1 - 22.43%))
Current Ratio = 1.04 (Total Current Assets 608.9m / Total Current Liabilities 585.5m)
Debt / Equity = 0.21 (Debt 704.7m / totalStockholderEquity, last quarter 3.34b)
Debt / EBITDA = -0.07 (Net Debt -54.3m / EBITDA 729.0m)
Debt / FCF = -0.40 (Net Debt -54.3m / FCF TTM 136.0m)
Total Stockholder Equity = 3.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.48% (Net Income 419.4m / Total Assets 17.3b)
RoE = 12.66% (Net Income TTM 419.4m / Total Stockholder Equity 3.31b)
RoCE = 20.50% (EBIT 703.9m / Capital Employed (Equity 3.31b + L.T.Debt 119.0m))
RoIC = 3.17% (NOPAT 546.0m / Invested Capital 17.2b)
WACC = 9.30% (E(4.21b)/V(4.92b) * Re(7.13%) + D(704.7m)/V(4.92b) * Rd(28.68%) * (1-Tc(0.22)))
Discount Rate = 7.13% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -76.26 | Cagr: -0.06%
[DCF] Terminal Value 69.63% ; FCFF base≈263.0m ; Y1≈230.6m ; Y5≈186.3m
[DCF] Fair Price = 42.51 (EV 2.59b - Net Debt -54.3m = Equity 2.64b / Shares 62.1m; r=9.30% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 66.96 | EPS CAGR: 1.07% | SUE: 0.32 | # QB: 0
Revenue Correlation: 72.12 | Revenue CAGR: 2.22% | SUE: 0.58 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.67 | Chg30d=+3.09% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=6.64 | Chg30d=+3.91% | Revisions=-25% | GrowthEPS=+0.3% | GrowthRev=+0.0%
EPS next Year (2027-12-31): EPS=6.72 | Chg30d=-0.44% | Revisions=+25% | GrowthEPS=+1.2% | GrowthRev=+3.2%